• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SUR1 通道亚基上调在帕金森病多巴胺能神经元变性中的作用。

Role of upregulation of the K channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease.

机构信息

Department of Physiology, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders and State Key Disciplines: Physiology, School of Basic Medicine, Qingdao University, Qingdao, China.

出版信息

Aging Cell. 2022 May;21(5):e13618. doi: 10.1111/acel.13618. Epub 2022 Apr 20.

DOI:10.1111/acel.13618
PMID:35441806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9124303/
Abstract

Accumulating evidence suggests that ATP-sensitive potassium (K ) channels play an important role in the selective degeneration of dopaminergic neurons in the substantia nigra (SN). Furthermore, the expression of the K channel subunit sulfonylurea receptor 1 (SUR1) is upregulated in the remaining nigral dopaminergic neurons in Parkinson's disease (PD). However, the mechanism underlying this selective upregulation of the SUR1 subunit and its subsequent roles in PD progression are largely unknown. In 3-, 6-, and 9-month-old A53T α-synuclein transgenic (α-SynA53T ) mice, only the SUR1 subunit and not SUR2B or Kir6.2 was upregulated, accompanied by neuronal damage. Moreover, the occurrence of burst firing in dopaminergic neurons was increased with the upregulation of the SUR1 subunit, whereas no changes in the firing rate were observed except in 9-month-old α-SynA53T mice. After interference with SUR1 expression by injection of lentivirus into the SN, the progression of dopaminergic neuron degeneration was delayed. Further studies showed that elevated expression of the transcription factors FOXA1 and FOXA2 could cause the upregulation of the SUR1 subunit in α-SynA53T mice. Our findings revealed the regulatory mechanism of the SUR1 subunit and the role of K channels in the progression of dopaminergic neuron degeneration, providing a new target for PD drug therapy.

摘要

越来越多的证据表明,三磷酸腺苷敏感性钾(K)通道在黑质(SN)中多巴胺能神经元的选择性退化中起着重要作用。此外,在帕金森病(PD)中,剩余的黑质多巴胺能神经元中 K 通道亚单位磺酰脲受体 1(SUR1)的表达上调。然而,SUR1 亚基这种选择性上调的机制及其在 PD 进展中的后续作用在很大程度上尚不清楚。在 3、6 和 9 月龄 A53T ɑ-突触核蛋白转基因(α-SynA53T)小鼠中,只有 SUR1 亚基而不是 SUR2B 或 Kir6.2 上调,伴随着神经元损伤。此外,随着 SUR1 亚基的上调,多巴胺能神经元的爆发性放电增加,而除了 9 月龄的 α-SynA53T 小鼠外,放电率没有变化。通过向 SN 注射慢病毒干扰 SUR1 表达后,多巴胺能神经元退化的进展被延迟。进一步的研究表明,转录因子 FOXA1 和 FOXA2 的高表达可导致 α-SynA53T 小鼠中 SUR1 亚基的上调。我们的研究结果揭示了 SUR1 亚基的调节机制以及 K 通道在多巴胺能神经元退化进展中的作用,为 PD 药物治疗提供了新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/7c0715a07257/ACEL-21-e13618-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/9883c6d4eb92/ACEL-21-e13618-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/280e202d4c9d/ACEL-21-e13618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/856342b671f0/ACEL-21-e13618-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/433282baf6a6/ACEL-21-e13618-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/7c0715a07257/ACEL-21-e13618-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/9883c6d4eb92/ACEL-21-e13618-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/280e202d4c9d/ACEL-21-e13618-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/856342b671f0/ACEL-21-e13618-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/433282baf6a6/ACEL-21-e13618-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed19/9124303/7c0715a07257/ACEL-21-e13618-g005.jpg

相似文献

1
Role of upregulation of the K channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease.SUR1 通道亚基上调在帕金森病多巴胺能神经元变性中的作用。
Aging Cell. 2022 May;21(5):e13618. doi: 10.1111/acel.13618. Epub 2022 Apr 20.
2
Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.KATP通道对细胞代谢紊乱的敏感性及其潜在的结构基础。
Acta Pharmacol Sin. 2016 Jan;37(1):134-42. doi: 10.1038/aps.2015.134.
3
Deletion of Kir6.2/SUR1 potassium channels rescues diminishing of DA neurons via decreasing iron accumulation in PD.PD 中通过减少铁积累来挽救 DA 神经元减少,Kir6.2/SUR1 钾通道的缺失起了作用。
Mol Cell Neurosci. 2018 Oct;92:164-176. doi: 10.1016/j.mcn.2018.08.006. Epub 2018 Aug 29.
4
Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels.黄芩素通过结合 SUR1 并激活三磷酸腺苷敏感性钾通道来减轻鱼藤酮诱导的 SH-SY5Y 细胞凋亡。
Acta Pharmacol Sin. 2024 Mar;45(3):480-489. doi: 10.1038/s41401-023-01187-3. Epub 2023 Nov 22.
5
Phenylephrine preconditioning in embryonic heart H9c2 cells is mediated by up-regulation of SUR2B/Kir6.2: A first evidence for functional role of SUR2B in sarcolemmal KATP channels and cardioprotection.胚胎心脏H9c2细胞中去氧肾上腺素预处理通过上调SUR2B/Kir6.2介导:SUR2B在肌膜KATP通道及心脏保护中的功能作用的首个证据
Int J Biochem Cell Biol. 2016 Jan;70:23-8. doi: 10.1016/j.biocel.2015.10.029. Epub 2015 Nov 10.
6
Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K channels by MgADP and metabolism.SUR C 端在 MgADP 和代谢物对β细胞和心脏 K 通道的差异调节中的作用。
J Physiol. 2018 Dec;596(24):6205-6217. doi: 10.1113/JP276708. Epub 2018 Oct 14.
7
N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2.SUR1 的 N 端跨膜结构域通过调节通道对 PIP2 的敏感性控制 Kir6.2 的门控。
J Gen Physiol. 2011 Mar;137(3):299-314. doi: 10.1085/jgp.201010557. Epub 2011 Feb 14.
8
The expression of K channel subunits in alpha-synuclein-transfected MES23.5 cells.K通道亚基在α-突触核蛋白转染的MES23.5细胞中的表达。
Ann Transl Med. 2018 May;6(10):170. doi: 10.21037/atm.2018.04.24.
9
ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K channels.三磷酸腺苷(ATP)结合但不水解将磺酰脲受体 1(SUR1)转换为激活钾通道的外向构象。
J Biol Chem. 2019 Mar 8;294(10):3707-3719. doi: 10.1074/jbc.RA118.005236. Epub 2018 Dec 26.
10
KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy.大鼠背根神经节中的 KATP 通道亚基:疼痛性轴突切断的改变。
Mol Pain. 2010 Jan 26;6:6. doi: 10.1186/1744-8069-6-6.

引用本文的文献

1
Changes in the Properties of Ethanol-Sensitive Molecular Targets During Maturation and Aging.成熟和老化过程中乙醇敏感分子靶点的性质变化
Adv Exp Med Biol. 2025;1473:299-316. doi: 10.1007/978-3-031-81908-7_13.
2
Targeting Glucose Metabolism: A Novel Therapeutic Approach for Parkinson's Disease.靶向葡萄糖代谢:帕金森病的一种新治疗方法。
Cells. 2024 Nov 13;13(22):1876. doi: 10.3390/cells13221876.
3
The impact of ATP-sensitive potassium channel modulation on mitochondria in a Parkinson's disease model using SH-SY5Y cells depends on their differentiation state.

本文引用的文献

1
Parkinson's Disease Genetics and Pathophysiology.帕金森病遗传学与病理生理学。
Annu Rev Neurosci. 2021 Jul 8;44:87-108. doi: 10.1146/annurev-neuro-100720-034518.
2
α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.α-突触核蛋白寡聚体诱导星形胶质细胞释放谷氨酸,并导致神经元过度的突触外 NMDA 受体活性,从而导致突触丢失。
J Neurosci. 2021 Mar 10;41(10):2264-2273. doi: 10.1523/JNEUROSCI.1871-20.2020. Epub 2021 Jan 22.
3
α-Synuclein Aggregates Increase the Conductance of Substantia Nigra Dopamine Neurons, an Effect Partly Reversed by the KATP Channel Inhibitor Glibenclamide.
三磷酸腺苷敏感性钾通道调节对帕金森病模型 SH-SY5Y 细胞中线粒体的影响取决于其分化状态。
J Bioenerg Biomembr. 2024 Aug;56(4):347-360. doi: 10.1007/s10863-024-10018-x. Epub 2024 Apr 30.
4
Sodium butyrate activates the K channels to regulate the mechanism of Parkinson's disease microglia model inflammation.丁酸钠通过激活 K 通道调节帕金森病小胶质细胞模型炎症的机制。
Immun Inflamm Dis. 2024 Mar;12(3):e1194. doi: 10.1002/iid3.1194.
5
Baicalein attenuates rotenone-induced SH-SY5Y cell apoptosis through binding to SUR1 and activating ATP-sensitive potassium channels.黄芩素通过结合 SUR1 并激活三磷酸腺苷敏感性钾通道来减轻鱼藤酮诱导的 SH-SY5Y 细胞凋亡。
Acta Pharmacol Sin. 2024 Mar;45(3):480-489. doi: 10.1038/s41401-023-01187-3. Epub 2023 Nov 22.
6
Nuance of inward rectifying potassium (Kir) channel dysfunctions in neurodegenerative diseases.神经退行性疾病中内向整流钾通道(Kir)功能障碍的细微差别。
Neural Regen Res. 2024 Jun 1;19(6):1195-1196. doi: 10.4103/1673-5374.385870. Epub 2023 Sep 22.
7
METTL14 Regulates the m6A Modification of TRAF6 to Suppress Mitochondrial Dysfunction and Ferroptosis in Dopaminergic Neurons via the cGAS-STING Pathway.METTL14 通过 cGAS-STING 通路调控 TRAF6 的 m6A 修饰抑制多巴胺能神经元线粒体功能障碍和铁死亡
Curr Mol Med. 2024;24(12):1518-1528. doi: 10.2174/0115665240263859231018110107.
α-突触核蛋白聚集增加黑质多巴胺神经元的电导率,该效应部分可被 KATP 通道抑制剂格列本脲逆转。
eNeuro. 2021 Jan 14;8(1). doi: 10.1523/ENEURO.0330-20.2020. Print 2021 Jan-Feb.
4
The role of K channel blockade and activation in the protection against neurodegeneration in the rotenone model of Parkinson's disease.K 通道阻断和激活在鱼藤酮帕金森病模型中对神经退行性变的保护作用。
Life Sci. 2020 Sep 15;257:118070. doi: 10.1016/j.lfs.2020.118070. Epub 2020 Jul 13.
5
Diagnosis and Treatment of Parkinson Disease: A Review.帕金森病的诊断与治疗:综述。
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
6
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease.衰老黑质中的氧化应激与帕金森病的病因学
Aging Cell. 2019 Dec;18(6):e13031. doi: 10.1111/acel.13031. Epub 2019 Aug 20.
7
Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications.帕金森病中的多巴胺转运体成像:抗帕金森药物治疗后的进展性变化及治疗调整
Intern Med. 2019 Jun 15;58(12):1665-1672. doi: 10.2169/internalmedicine.2489-18. Epub 2019 Feb 25.
8
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.帕金森病中的突触、线粒体和溶酶体功能障碍。
Trends Neurosci. 2019 Feb;42(2):140-149. doi: 10.1016/j.tins.2018.11.001. Epub 2018 Nov 30.
9
Genomic DNA levels of mutant alpha-synuclein correlate with non-motor symptoms in an A53T Parkinson's disease mouse model.突变型 alpha-突触核蛋白的基因组 DNA 水平与 A53T 帕金森病小鼠模型的非运动症状相关。
Neurochem Int. 2018 Mar;114:71-79. doi: 10.1016/j.neuint.2018.01.006. Epub 2018 Jan 23.
10
Genetics of Parkinson's disease and related disorders.帕金森病及相关疾病的遗传学。
J Med Genet. 2018 Feb;55(2):73-80. doi: 10.1136/jmedgenet-2017-105047. Epub 2017 Nov 18.